Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (671-680 of 1,058) with videos related to

Pageof 106
Sort By:
Oncotarget|March 22, 2018
First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLLJohn C Byrd, Stephen Smith, Nina Wagner-Johnston, et al.
British Journal of Haematology|September 15, 2009
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemiaKristie A Blum, Anjani Advani, Louis Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909Lloyd E Damon, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Molecular Pharmaceutics|April 15, 2015
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous LeukemiaHong Li, Songlin Xu, Jishan Quan, et al.
Blood|March 22, 2003
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinJennifer L Aron, Mark R Parthun, Guido Marcucci, et al.
Oncotarget|June 21, 2019
Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLLJohn C Byrd, Stephen Smith, Nina Wagner-Johnston, et al.
Journal of Geriatric Oncology|April 21, 2018
Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)Michael Tallarico, Jared C Foster, Drew Seisler, et al.
International Journal of Cancer|September 16, 2011
Quantitative analyses of DAPK1 methylation in AML and MDSRainer Claus, Björn Hackanson, Anna R Poetsch, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Pageof 106

Showing results (671-680 of 1,058) with videos related to

Sort By:
Pageof 106
Oncotarget|March 22, 2018
First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLLJohn C Byrd, Stephen Smith, Nina Wagner-Johnston, et al.
British Journal of Haematology|September 15, 2009
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemiaKristie A Blum, Anjani Advani, Louis Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909Lloyd E Damon, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Molecular Pharmaceutics|April 15, 2015
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous LeukemiaHong Li, Songlin Xu, Jishan Quan, et al.
Blood|March 22, 2003
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinJennifer L Aron, Mark R Parthun, Guido Marcucci, et al.
Oncotarget|June 21, 2019
Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLLJohn C Byrd, Stephen Smith, Nina Wagner-Johnston, et al.
Journal of Geriatric Oncology|April 21, 2018
Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)Michael Tallarico, Jared C Foster, Drew Seisler, et al.
International Journal of Cancer|September 16, 2011
Quantitative analyses of DAPK1 methylation in AML and MDSRainer Claus, Björn Hackanson, Anna R Poetsch, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Pageof 106